Lv1
12 积分 2024-06-29 加入
Targeting and engineering long non-coding RNAs for cancer therapy
14天前
已完结
Complementary Alu sequences mediate enhancer–promoter selectivity
1个月前
已完结
Trispecific anti-CD3/BCMA/CD38 antibodies for multiple myeloma: a patent evaluation of US20240132615
6个月前
已完结
Trispecific antibodies take to the clinic
7个月前
已完结
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia
7个月前
已完结
Talquetamab, a T-Cell–Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma
7个月前
已完结
Trispecific antibodies for cancer immunotherapy
7个月前
已完结
Trispecific antibodies for cancer immunotherapy
7个月前
已完结
A Trispecific Antibody Induces Potent Tumor-Directed T-Cell Activation and Antitumor Activity by CD3/CD28 Co-Engagement
7个月前
已完结
Engineering CD3/CD137 Dual Specificity into a DLL3-Targeted T-Cell Engager Enhances T-Cell Infiltration and Efficacy against Small-Cell Lung Cancer
7个月前
已完结
皖公网安备34019202002308
